To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Needle-free Drug Delivery Devices Market size was valued at USD 15.07 Billion in 2024 and is poised to grow from USD 16.11 Billion in 2025 to USD 27.48 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026–2033).

    The global needle-free drug delivery devices market is defined by its competitive environment. This landscape includes all market players striving to gain the largest market share. This intense competition has driven the market's growth. Some industry leaders include 3M, Pfizer, Johnson & Johnson, and Medtronic. These companies dominate the market. They have achieved this by using their best advantages. They include tremendous R&D efforts and a wide range of products. 'PenJet (USA)', 'Zealand Pharma (Denmark) ', 'UCB S.A. (Belgium) ', 'PharmaJet (USA) ', '3M (USA) ', 'Verdict Media Limited (UK) ', 'INJEX Pharma AG (Germany) ', 'Antares Pharma (USA) ', 'Endo Pharmaceuticals Inc. (USA) ', 'Bioject Medical Technologies, Inc. (USA) ', 'Crossject SA (France) ', 'MannKind Corporation (USA) ', 'Mika Medical Co. (South Korea) ', 'Halozyme, Inc. (USA) ', 'Akra Dermojet (Turkey) ', 'Zydus Group (India) ', 'Ferring B.V. (Switzerland) ', 'Gerresheimer AG (Germany) ', 'AptarGroup, Inc. (USA) ', 'MIIST Therapeutics (USA)'

    The market has seen the entry of new devices which are more precisely efficient. This is because of the continuous improvements in needle-free drug delivery technology. The introduction of advanced devices like transdermal patches, along with micro-needles and jet injectors, has been made possible with this development. These new technologies can be applied to many cases. These tools are only becoming more precise and are suited to varying applications as technology keeps developing.

    Expanding Applications in Healthcare: The market was witnessing a notable trend. Drug delivery devices that didn’t use needles could be applied elsewhere apart from traditional insulin and vaccines delivery. The market also served specialized therapeutics and biologic in addition to its previous purposes. Technological advancements can be credited for the use of these devices in additional applications. As the requirement for controlled and accurate drug administration persists, the market can expect further innovations and uses.

    The market's dominant region is North America. Its increased usage of innovative technologies in the field of medicine and a well-established healthcare infrastructure has steeled its top market position. Other factors that contribute to North America's supremacy are its supportive regulatory framework and continuous R&D efforts.

    Feedback From Our Clients

    Global Needle-free Drug Delivery Devices Market

    Report ID: SQMIG35I2250

    $5,300
    BUY NOW